| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.026 | 0.9 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |